Vivmark Residential published an updated investor presentation and operating update in connection with its participation in the BofA Securities Global Real Estate Conference. The company, formed by the August 2026 merger of AvalonBay and Equity Residential, established a 2026 Same Store Residential revenue outlook of 2% at the midpoint and reported 95.7% physical occupancy.
West Coast Community Bancorp Investor Presentation
West Coast Community Bancorp announced that its common stock has been approved for listing on the Nasdaq Stock Market under the ticker 'WCCB', effective September 16, 2026. In connection with the uplisting, the company filed a formal investor presentation (Exhibit 99.2) to be used in meetings with shareholders and institutional investors. No new shares are being issued and no proceeds are being raised as part of this listing process.
Cousins Properties filed a formal investor presentation for the BofA Securities Global Real Estate Conference 2026. The presentation highlights the company's 22.3 million square foot Sun Belt office portfolio, its 5.6x Net Debt/EBITDA leverage ratio, and a 5.1 million square foot land bank for future development.
Xenia Hotels & Resorts, Inc. has filed its September 2026 Investor Presentation, which senior management intends to use for upcoming meetings with current and potential investors and analysts. The presentation provides an overview of the company's portfolio, strategy, and outlook for the lodging industry.
Worthington Enterprises announced it will host an Investor and Analyst Day on November 10, 2026, to provide updates on its strategy and long-term growth opportunities. The company also announced the renaming of its Building Products segment to Building Performance Solutions and its Consumer Products segment to Trade & Specialty Solutions to better reflect their market focus.
Apple Hospitality REIT, Inc. has made available an updated investor presentation for use at various upcoming conferences and meetings. The presentation includes operating statistics for August and September 2026 and provides an overview of the company's hotel portfolio and financial strategy.
Capital One Financial Corporation announced that it will present at the Barclays 24th Annual Global Financial Services Conference on September 16, 2026. The presentation will be held in New York and made available via a live audio webcast on the company's investor relations website.
Spectral AI filed a formal investor presentation deck detailing its commercialization strategy for the DeepView System following its May 2026 FDA De Novo classification. The presentation highlights the company's $250 million in non-dilutive government funding and its $150 million contracted revenue base with BARDA for burn and trauma center deployments. The company is transitioning from clinical validation to commercial launch in the US, UK, and Australia.
Veradigm Inc. filed a formal investor presentation deck in connection with its participation in the 2026 Jefferies Healthcare Services and Technology Conference and the Deutsche Bank 2026 Healthcare Summit. The presentation outlines the company's 'reset, recover, reignite' strategy and provides preliminary 2025 financial expectations as it works toward relisting on a national securities exchange.
Counterparty
Jefferies Healthcare Services and Technology Conference
Abeona Therapeutics Inc. filed an updated investor presentation for its appearance at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The presentation provides a strategic update on the company's clinical pipeline and corporate milestones to the investment community.
Bandwidth Inc. filed a formal investor presentation deck to be used at various investor conferences during the third quarter of 2026. The presentation provides a strategic overview of the company's product offerings, platform value proposition, and anticipated market growth.
Astrana Health, Inc. filed an updated corporate investor presentation for September 2026 to be used in upcoming conferences and meetings. The presentation covers the company's business strategy, expansion plans, and financial targets, including its use of artificial intelligence capabilities.
Evommune, Inc. has filed an updated corporate presentation as an exhibit to its 8-K, providing a strategic overview of its clinical-stage portfolio including EVO756, EVO301, and EVO646. The presentation outlines the company's focus on chronic inflammatory diseases and highlights its leadership team's track record of approximately 30 approved NDAs and BLAs.
Aspen Aerogels filed a formal investor presentation deck on September 15, 2026, to be used for discussions with investors and analysts. The presentation includes the company's financial outlook for the third quarter of 2026 and strategic commentary on its EV thermal barrier and Energy Industrial markets.
D-Wave Quantum Inc. announced its participation as a platinum sponsor at the Quantum World Congress 2026, where it will showcase its dual-platform quantum computing strategy. The company plans to present real-world results from its annealing systems and provide technical updates on its dual-rail gate-model architecture designed for error correction. Executives, including Chief Science Officer Dr. Robert Schoelkopf, will deliver a plenary address and participate in panels regarding quantum utility and federal policy.
Ingram Micro is hosting its inaugural 2026 Capital Markets Day to outline its transformation into a B2B intelligent operating system and introduce a multi-year financial framework through 2029. The company established long-term targets including a net sales CAGR of 4-6% and a non-GAAP net income CAGR of 11-13%, while also reaffirming that Q3 2026 results are expected at the high end of previously provided guidance.
Earnings call
Sep 15, 2026, 11:15 AM ET
“For decades, our scale, reach, and relationships have made Ingram Micro a trusted partner across the global technology ecosystem. Today, we are entering a new chapter as we build on those strengths to create the industry’s B2B intelligent operating system at scale.”
Paul Bay, Ingram Micro’s Chief Executive Officer
“In the short term, for the third quarter of fiscal 2026 we expect to achieve results at the high end of the range of the guidance we provided on our second quarter earnings call in late July.”
Mike Zilis, Ingram Micro’s Chief Financial Officer
Fifth Third Bancorp is presenting at the 2026 Barclays Global Financial Services Conference on September 15, 2026. The presentation highlights the company's $300 billion asset base, its recent acquisition of Comerica, and its strategic focus on expansion in the Southeast and Texas markets.
Public Storage has posted a new investor presentation to its website for use at an upcoming investor conference. The filing, made under Item 7.01, serves as a Regulation FD disclosure to provide the public with the same strategic and operational information being shared with institutional investors.
CitroTech Inc. has released a formal investor presentation detailing its strategic transformation, including its NYSE American uplisting and the HexiTech joint venture. The presentation outlines the company's path toward the 2027 fire season and its expansion into a certified partner network across six states and Alberta.
Caris Life Sciences announced that its management team will use a formal investor presentation for meetings with current and potential investors at the Morgan Stanley 24th Annual Global Healthcare Conference beginning September 14, 2026. The presentation will be made available on the company's investor relations website.
Counterparty
Morgan Stanley 24th Annual Global Healthcare Conference
CubeSmart filed a formal investor presentation deck dated September 2026 to be used in presentations to investors. The presentation highlights the company's $12.5 billion enterprise value, its portfolio of 1,534 properties, and its five-year growth metrics including a 57% increase in dividends.
RGC Resources Inc. filed a formal investor presentation as an exhibit to its 8-K. The presentation is intended for use in meetings with investors and analysts to discuss the company's strategic and operational highlights.
Westwater Resources Executive Chairman Terence Cryan presented at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The company filed its formal investor presentation deck which provides strategic updates on its business plan, including the development of the Kellyton Graphite Plant and the Coosa Graphite Deposit.
M&T Bank Corporation has filed a formal investor presentation for the third quarter of 2026. The company intends to use this presentation for ongoing conversations with investors and analysts regarding its business and financial outlook.
Associated Banc-Corp has filed a formal investor presentation (Exhibit 99.1) to be used by executives in upcoming meetings with investors and analysts. The presentation highlights the company's 2H 2026 strategic themes, including organic growth momentum and the integration of American National Bank, with a system conversion expected in October 2026.
Stewards, Inc. has furnished a corporate presentation deck (Exhibit 99.1) detailing its business strategy, operations, and outlook for September 2026. The presentation outlines the company's integrated financial platform strategy, which combines private credit, real assets, and developing digital infrastructure initiatives.
iBio, Inc. has updated its corporate presentation for use in meetings with investors and analysts. The presentation, titled 'Breakthrough Antibodies for Obesity and Cardiometabolic Diseases', highlights the company's strategic focus and product candidate pipeline as of September 2026.
Boot Barn Holdings announced its participation in the Goldman Sachs Global Consumer and Retail Conference and the Piper Sandler Growth Frontiers Conference. The company provided a business update noting 2% same-store sales growth in fiscal August and September to date, and reaffirmed its Q2 guidance while expecting total sales and EPS to hit the high end of previously announced ranges.
Scienture Holdings, Inc. has posted a revised investor presentation to its corporate website and filed it as an exhibit to this 8-K. The company intends to use the presentation in upcoming meetings with analysts and potential investors to discuss its projects, financial performance, and growth opportunities.
Emergent BioSolutions CEO Joseph C. Papa is presenting at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The company filed a formal investor presentation deck as an exhibit, which outlines its strategy for combating public health threats and provides updates on its medical countermeasure portfolio, including CYFENDUS and NARCAN.